Judith is a patent specialist having over 20 years of experience in complex multijurisdictional patent litigation as well as extensive experience in pharma regulatory matters and transactional life sciences. Judith is also one of the firms Unified Patent Court Representatives.

Judith's experience

  • Advised Torrent, a leading pharmaceutical company, on patent litigation against Sanofi related to teriflunomide.

  • Assisting a biotechnology company with patent litigation relating to patent entitlement issues in the field of functional plant-based proteins

  • Advised Lotus, a leading pharmaceutical company, regarding several aspects of the SPC manufacturing waiver

  • Assisted Torrent Pharmaceuticals Limited, a pharmaceutical company, in challenging the data exclusivity term and Supplementary Protection Certificate (SPC) of teriflunomide as owned by Sanofi.

  • Advised Advanced Cell Diagnostics, a leading biotechnology company, on acting on their behalf by handling a UPC infringement action against Molecular Instruments Inc. and defending a revocation action regarding the underlying patent

  • Acting for Teva (Alongside the UK who are coordinating) in proceedings in the Dutch Court against Bristol-Myers Squibb in relation to the blockbuster anticoagulant drug Eliquis ($8bn worldwide sales).

Credentials

  • 2022
    Joined Pinsent Masons
  • 2006
    Admitted to bar - New York
  • 2006
    Columbia University, New York - LL.M.
  • 2000
    Admitted to bar - The Netherlands
  • 1999
    Utrecht University - LL.M.
  • 1998
    Utrecht University - Chemistry (MSc.)
Load More

Out-Law / Insight by Judith Krens

We are processing your request. \n Thank you for your patience. An error occurred. This could be due to inactivity on the page - please try again.